Connect Biopharma Holdings Ltd
CNTB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001835268
No open-market purchases or sales by Connect Biopharma Holdings Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $33.1M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Connect Biopharma Holdings Ltd as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −1 vs. Q4 2021
- Shares held
- 17.7M
- +740.6K (+4.4%) vs. Q4 2021
- Total value
- $53.4M
- −$34.0M (−38.9%) vs. Q4 2021
- New holders
- 9
- 12 more added
- Sold out
- 10
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $33.1M |
| Q1 2026 | 41 | $32.4M |
| Q4 2025 | 29 | $23.9M |
| Q3 2025 | 16 | $2.45M |
| Q2 2025 | 17 | $2.40M |
| Q1 2025 | 13 | $1.56M |
| Q4 2024 | 14 | $4.37M |
| Q3 2024 | 11 | $4.23M |
| Q2 2024 | 12 | $4.52M |
| Q1 2024 | 12 | $6.87M |
| Q4 2023 | 15 | $8.40M |
| Q3 2023 | 14 | $8.22M |
| Q2 2023 | 16 | $11.7M |
| Q1 2023 | 16 | $10.9M |
| Q4 2022 | 20 | $9.60M |
| Q3 2022 | 25 | $16.4M |
| Q2 2022 | 29 | $13.0M |
| Q1 2022 | 28 | $53.4M |
| Q4 2021 | 29 | $87.4M |
| Q3 2021 | 20 | $467.5M |
| Q2 2021 | 16 | $372.4M |
| Q1 2021 | 26 | $284.6M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Connect Biopharma Holdings Ltd; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 3 | $0 | 0.00% | +3 | New |
| Simplex Trading, LLC | 1,255 | $3.00K | 0.00% | −6,977−84.8% | Reduced |
| Citigroup Inc | 1,053 | $3.00K | 0.00% | −1,910−64.5% | Reduced |
| Tower Research Capital LLC (TRC) | 1,241 | $4.00K | 0.00% | +1,241 | New |
| UBS Group AG | 1,861 | $6.00K | 0.00% | +1,080+138.3% | Added |
| JPMorgan Chase & Co | 3,920 | $12.0K | 0.00% | +1,052+36.7% | Added |
| Chicago Partners Investment Group LLC | 19,588 | $17.0K | 0.00% | −2,304−10.5% | Reduced |
| Morgan Stanley | 8,836 | $27.0K | 0.00% | +3,537+66.7% | Added |
| Vident Investment Advisory, LLC | 18,062 | $55.0K | 0.00% | +18,062 | New |
| Geode Capital Management, LLC | 19,032 | $57.0K | 0.00% | +19,032 | New |
| Goldman Sachs Group Inc | 19,281 | $58.0K | 0.00% | +7,490+63.5% | Added |
| CSS LLC | 20,000 | $60.0K | 0.00% | +20,000 | New |
| Renaissance Technologies LLC | 23,500 | $71.0K | 0.00% | +12,700+117.6% | Added |
| Woodline Partners LP | 43,871 | $132.0K | 0.00% | +43,871 | New |
| Invesco Ltd. | 60,449 | $183.0K | 0.00% | +34,820+135.9% | Added |
| Boothbay Fund Management, LLC | 77,851 | $235.0K | 0.01% | +48,167+162.3% | Added |
| Kynam Capital Management, LP | 227,759 | $688.0K | 0.22% | +227,759 | New |
| Octagon Capital Advisors LP | 279,921 | $845.0K | 0.18% | 00.0% | Unchanged |
| Bank of America Corp | 296,136 | $894.0K | 0.00% | +9,007+3.1% | Added |
| Barclays PLC | 313,732 | $947.0K | 0.00% | +313,732 | New |
| RTW Investments, LP | 446,564 | $1.35M | 0.03% | −3,436−0.8% | Reduced |
| Sio Capital Management, LLC | 597,678 | $1.80M | 0.73% | +597,678 | New |
| Ikarian Capital, LLC | 677,859 | $2.05M | 0.62% | +415,622+158.5% | Added |
| Adage Capital Partners GP, L.L.C. | 1,437,500 | $4.34M | 0.01% | +187,500+15.0% | Added |
| Janus Henderson Group PLC | 1,599,826 | $4.81M | 0.00% | +1,173,974+275.7% | Added |
| BlackRock Inc. | 2,236,392 | $6.75M | 0.00% | +92,632+4.3% | Added |
| FMR LLC | 2,283,269 | $6.89M | 0.00% | −1,134,295−33.2% | Reduced |
| Ra Capital Management, L.P. | 6,991,003 | $21.1M | 0.46% | 00.0% | Unchanged |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −647,057−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −175,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −123,109−100.0% | Sold out |
| DLD Asset Management, LP | 0 | $0 | 0.00% | −121,707−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −25,412−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,212−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −15,632−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −15,273−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −6−100.0% | Sold out |